McGlone Suttner Wealth Management’s AbbVie ABBV Stock Holding History

McGlone Suttner Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$3.2M	Buy	12,230 +70	+0.6%	+$17.9K	0.37%	28
2026 Q2	$3.06M	Buy	12,160 +173	+1%	+$37.2K	0.36%	31
2026 Q1	$2.61M	Buy	11,987 +258	+2%	+$57.2K	0.35%	33
2025 Q4	$2.68M	Buy	11,729 +256	+2%	+$58.3K	0.36%	27
2025 Q3	$2.66M	Buy	11,473 +173	+2%	+$35.2K	0.37%	27
2025 Q2	$2.1M	Buy	11,300 +256	+2%	+$47.6K	0.32%	34
2025 Q1	$2.31M	Buy	11,044 +818	+8%	+$159K	0.38%	27
2024 Q4	$1.82M	Buy	10,226 +19	+0.2%	+$3.49K	0.3%	35
2024 Q3	$2.02M	Buy	10,207 +1,161	+13%	+$217K	0.42%	28
2024 Q2	$1.4M	Sell	9,046 -1,255	-12%	-$208K	0.29%	33
2024 Q1	$1.88M	Buy	10,301 +1,255	+14%	+$216K	0.35%	29
2023 Q4	$1.4M	Buy	9,046 +390	+5%	+$56.9K	0.28%	33
2023 Q3	$1.29M	Buy	8,656 +139	+2%	+$20.4K	0.3%	35
2023 Q2	$1.15M	Buy	8,517 +109	+1%	+$16K	0.26%	43
2023 Q1	$1.34M	Buy	8,408 +79	+0.9%	+$12.1K	0.34%	33
2022 Q4	$1.35M	Buy	+8,329	New	+$1.28M	0.43%	33

Other funds holding ABBV

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return

McGlone Suttner Wealth Management's ABBV Position: Q3 2026 in Review

McGlone Suttner Wealth Management increased its AbbVie (ABBV) stake by 0.58% in Q3 2026, buying an estimated $17.9K and bringing the position to 12,230 shares worth $3.2M. The position accounts for 0.37% of the portfolio, ranked #28.

McGlone Suttner Wealth Management first reported a position in ABBV in Q4 2022 and has held it in 16 quarters since. 2,709 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

McGlone Suttner Wealth Management held 12,230 shares of AbbVie worth $3.2M as of Q3 2026.
McGlone Suttner Wealth Management bought 70 AbbVie shares in Q3 2026, an estimated $17.9K.
AbbVie made up 0.37% of McGlone Suttner Wealth Management's portfolio in Q3 2026, its #28 holding.
McGlone Suttner Wealth Management first reported a position in AbbVie in Q4 2022 and has held it in 16 quarters since.
2,709 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on McGlone Suttner Wealth Management's 13F filing for Q3 2026, filed 13 Oct 2026.